REGN7075
REGN7075 is a bispecific antibody from Regeneron Pharmaceuticals, in registered phase 2 trials for non-small-cell lung cancer, small-cell lung cancer.
Overview
REGN7075 is listed on ClinicalTrials.gov as an intervention in 1 registered phase 2 trial sponsored by Regeneron Pharmaceuticals, in non-small-cell lung cancer, small-cell lung cancer. A bispecific antibody, as described in the registry record: one molecule binds two different targets, most often a tumour antigen and an immune cell or a second tumour pathway. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.
A bispecific antibody, as described in the registry record: one molecule binds two different targets, most often a tumour antigen and an immune cell or a second tumour pathway.
1.One arm of REGN7075 binds its target on the cancer cell.
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Landmark trials
Latest papers
topQuery for this drug: (TITLE:"REGN7075" OR ABSTRACT:"REGN7075" OR TITLE:"EGFRxCD28 bispecific immunotherapy" OR ABSTRACT:"EGFRxCD28 bispecific immunotherapy" OR TITLE:"marlotamig" OR ABSTRACT:"marlotamig") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about REGN7075, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentUbamatamab
Shares A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC), Regeneron and the tags pipeline, registry-only.
- TreatmentVistusertib
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
- TreatmentAU-007
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
- TreatmentOR502
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
- TreatmentTNG260
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
- TreatmentTNO155
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
- TreatmentAMT-116
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
- TreatmentRoginolisib
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.